<DOC>
	<DOCNO>NCT00292890</DOCNO>
	<brief_summary>Background aim : - In Netherlands patient diabetes mellitus treat insulin , use insulin pen insulin administration . The injection technique influence absorption rate insulin . - The aim study compare effect insulin injection use 5 mm insulin needle insulin injection use longer needle , HbA1c , bloodglucose level , hypoglycaemic event , bleeding , bruising , insulin leakage pain perception . - Study Hypothesis : 'Insulin inject needle 5 mm give without skinfold . The length needle influence HbA1c level bloodglucose level â€™ .</brief_summary>
	<brief_title>Which Needle Length Injecting Insulin</brief_title>
	<detailed_description>- In randomise , clinical trial cross-over design , 52 patient Diabetes type 1 2 use 8 12 mm needle , randomise two group . - Group I start use 5 mm needle insulin administration , 13 week group I return previously use 8 12 mm needle - Group II continue use 8 12 mm needle , 13 week group II start use 5 mm needle insulin administration . - During visit HbA1c level measure copy make logbook patient blood glucose measurement . - Insulin dose number experienced hypoglycaemic event register visit . - The opinion experience patient regard different needle obtain use questionnaire . - Within-group analysis compute , use Wilcoxon sign Ranks Test . Between-group analysis compute use Mann-Whitney U test .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Insulin , Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<criteria>male female diagnose diabetes Type 1 2 use insulin least one year use insulin pen needle 8mm long 18 year older capable read write information prepare , capable signing informed consent patient change insulin dosage n't keep administration change HbA1c vary 15 % past year use needle 5 6mm hypoglycaemia unawareness pregnant want become pregnant BMI &lt; 18 skinfold thickness 10 mm less injection site ( abdomen thigh ) hemoglobinopathy could limit ability haemoglobin glycated skin problem like lipodystrofie</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2005</verification_date>
	<keyword>injection device</keyword>
	<keyword>injection technique</keyword>
	<keyword>insulin needle</keyword>
	<keyword>insulin administration</keyword>
</DOC>